217.13USD+1.09%Mkt Cap: 383.62B USDP/E: 105.92Last update: 2026-06-03
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimm…
Industry Peers
Drug Manufacturers - GeneralIndicators:|
Key Statistics
Company
Market Cap383.62B USD
Enterprise Value448.23B USD
Revenue (TTM)62.82B USD
Gross Profit42.96B USD
Net Income (TTM)4.23B USD
Revenue/Share35.50 USD
Last Price217.13 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees57.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS00287Y1091
Valuation
P/E (Trailing)105.92
P/E (Forward)13.41
PEG0.60
EV/EBITDA14.98
EV/Revenue7.14
P/S6.12
P/B-57.80
EPS (TTM)2.03
EPS (Forward)16.23
52W Range
181.7356% of range244.81
52W High244.81 USD
52W Low181.73 USD
Profitability
Gross Margin70.24%
Oper. Margin32.16%
EBITDA Margin47.62%
Profit Margin6.91%
ROE-129.24%
ROA3.15%
Growth
Revenue Growth12.40%
Earnings Growth-46.20%
Cash Flow & Leverage
Operating CF19.03B USD
CapEx (TTM)1.21B USD
FCF Margin33.13%
FCF Yield5.43%
Net Debt63.52B USD
Net Debt/EBITDA2.12
Balance Sheet
Debt/Equity-20.64
Current Ratio0.80
Quick Ratio0.52
Book Value/Sh-3.7670 USD
Cash/Share5.315 USD
Dividends
Fwd Div Rate6.920 USD
Trail. Div Rate6.740 USD
Div. Yield3.17%
5Y Avg Yield3.62%
Payout Ratio325.98%
Ex-Div DateApr 15, 2026
Pay DateMay 15, 2026
Analyst Consensus
Rating1.8 (Buy)
Target (Mean)252.90 USD
Target Range184.00 USD – 328.00 USD
# Analysts29
Ownership
Shares Out.1.77B
Float1.76B
Insiders0.11%
Institutions76.84%
Short Interest
Short Ratio3.4d
Short % Float1.42%
Short % Out.1.28%
Shares Short22.59M
Short (prev mo.)21.85M
Technical
SMA 50208.23 (+4.3%)
SMA 200219.59 (-1.1%)
Beta0.30
S&P 52W Chg27.70%
Avg Vol (30d)5.40M
Avg Vol (10d)5.42M
Technical Indicators
RSI (14)58.9
MACD2.2828
MACD Signal1.7420
MACD Hist.+0.5408
BB Upper221.11 USD
BB Middle211.09 USD
BB Lower201.08 USD
BB Width9.49%
ATR (14)5.272 USD
Vol Ratio (20d)1.26x